Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Sponsor
AbbVie (Industry)
Overall Status
Recruiting
CT.gov ID
NCT03850782
Collaborator
(none)
490
113
2
76
4.3
0.1

Study Details

Study Description

Brief Summary

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.

Condition or Disease Intervention/Treatment Phase
  • Drug: Bimatoprost (SR)
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
490 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Actual Study Start Date :
Feb 28, 2019
Anticipated Primary Completion Date :
Jan 29, 2025
Anticipated Study Completion Date :
Jun 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Bimatoprost SR - Dose A

Study Eye: Participants will receive 1 - 3 Cycles of Bimatoprost SR administrations of Dose A Fellow Eye: The eye that does not receive Bimatoprost SR treatment will receive standard of care or up to one administration of Bimatoprost SR.

Drug: Bimatoprost (SR)
Study Eye: Cycles 1 - 3 administrations through the PRN treatment period. Fellow Eye: Standard of care or Bimatoprost SR.

Experimental: Bimatoprost SR - Dose B

Study Eye: Participants received 1-3 Cycles of Bimatoprost SR administrations of Dose B Fellow Eye: The eye that does not receive Bimatoprost SR treatment will receive standard of care or up to one administration of Bimatoprost SR.

Drug: Bimatoprost (SR)
Study Eye: Cycles 1 - 3 administrations through the PRN treatment period. Fellow Eye: Standard of care or Bimatoprost SR.

Outcome Measures

Primary Outcome Measures

  1. Retreatment or rescue administered for IOP [Up to 48 months]

    Treatment modality determined by investigator.

  2. Number of patients experiencing a treatment emergent adverse event [Baseline up to 48 months]

    The number of patients who experienced one or more TEAE during the 48 month treatment period.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of either Diagnosis of either open angle glaucoma (OAG) (i.e., primary OAG, pseudoexfoliation glaucoma, pigmentary glaucoma) or ocular hypertension requiring intraocular pressure-lowering treatment.
Exclusion Criteria:
  • Concurrent or anticipated enrollment in another investigational drug or device study or participation in such a study within 2 months prior to enrolling in this study.

  • Previous administration with Bimatoprost SR in the study eye.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Walman Eye Center /ID# 235240 Sun City Arizona United States 85351
2 Atlantis Eye Care /ID# 235530 Huntington Beach California United States 92647
3 Lakeside Vision Center /ID# 234970 Irvine California United States 92604
4 Global Research Foundation /ID# 237350 Los Angeles California United States 90041-1718
5 The Eye Research Foundation /ID# 234521 Newport Beach California United States 92663-3637
6 Byers Eye Institute Stanford /ID# 235544 Palo Alto California United States 94303
7 Foothill Eye Institute /ID# 235640 Pasadena California United States 91107
8 Connecticut Eye Consultants P.C. /ID# 234981 Danbury Connecticut United States 06810
9 Specialty Retina Center /ID# 236045 Coral Springs Florida United States 33067
10 Segal Drug Trials, Inc /ID# 235784 Delray Beach Florida United States 33484
11 International Research Center /ID# 238050 Tampa Florida United States 33603
12 Thomas Eye Group PC /ID# 235737 Sandy Springs Georgia United States 30328
13 Indiana University - Glick Eye Institute /ID# 235886 Indianapolis Indiana United States 46202
14 Midwest Eye Institute /ID# 237876 Indianapolis Indiana United States 46290
15 Tulane University /ID# 237632 New Orleans Louisiana United States 70112-2699
16 Ophthalmic Consultants of Boston /ID# 236534 Boston Massachusetts United States 02129
17 Clinical Eye Research of Boston LLC /ID# 234966 Winchester Massachusetts United States 01890
18 University of Michigan, Kellogg Eye Center /ID# 236496 Ann Arbor Michigan United States 48105
19 Fraser Eye Center /ID# 235790 Fraser Michigan United States 48026
20 Silverstein Eye Centers /ID# 237881 Kansas City Missouri United States 64034
21 Moyes Eye Center PC /ID# 234989 Kansas City Missouri United States 64154
22 Alterman Modi & Wolter /ID# 235248 Poughkeepsie New York United States 12603-2455
23 The Ohio State University /ID# 236790 Columbus Ohio United States 43210-1257
24 AMA Eyes Research Institute /ID# 235542 Marysville Ohio United States 43040
25 Dean McGee Eye Institute /ID# 236823 Oklahoma City Oklahoma United States 73104
26 Oklahoma Eye Surgeons /ID# 235849 Oklahoma City Oklahoma United States 73112
27 Drs Fine Hoffman & Sims LLC /ID# 235918 Eugene Oregon United States 97401
28 Ophthalmic Partners, PC /ID# 235741 Bala-Cynwyd Pennsylvania United States 19004
29 Scott and Christie and Associates /ID# 234593 Cranberry Township Pennsylvania United States 16066
30 Black Hills Regional Eye Institute /ID# 235075 Rapid City South Dakota United States 57701
31 Vance Thompson Vision /ID# 235072 Sioux Falls South Dakota United States 57108
32 Eye Specialty Group /ID# 235721 Memphis Tennessee United States 38120
33 Vanderbilt University Medical Center /ID# 237177 Nashville Tennessee United States 37232-0011
34 Advancing Vision Research /ID# 236681 Smyrna Tennessee United States 37167
35 ATX Clinical Trials Inc. dba Keystone Research /ID# 235868 Austin Texas United States 78731
36 Medical Center Ophthalmology Associates - Keystone Research /ID# 235787 San Antonio Texas United States 78240
37 Southern Utah Medical Research /ID# 235602 Saint George Utah United States 84790
38 Piedmont Eye Center /ID# 234534 Lynchburg Virginia United States 24502
39 Consultorio Oftalmologico Dr. Fabian Lerner /ID# 235855 Caba Buenos Aires Argentina 1122
40 Hospital Universitario Austral /ID# 237727 Pilar Buenos Aires Argentina 1629
41 Oftalmología Global /ID# 239187 Rosario Santa Fe Argentina 2000
42 Hospital Italiano /ID# 235851 Buenos Aires Argentina 1181
43 Centro Privado de Ojos /ID# 241283 Ciudad Autonoma Buenos Aires Argentina 1033
44 Centro oftalmologico Dr Charles /ID# 235881 Ciudad de Buenos Aires Argentina 1116
45 Oftar Mendoza /ID# 240535 Mendoza Argentina 1019
46 Eye Surgery Associates /ID# 235873 East Melbourne Victoria Australia 3002
47 Multiprofile Hospital for Active Treatment "Lozenetz" /ID# 244053 Sofiya Sofia Bulgaria 1407
48 Medical Center Oxycom Burgas /ID# 235580 Burgas Bulgaria 8008
49 UMHAT Sveti Georgi /ID# 237027 Plovdiv Bulgaria 4002
50 MHAT Hadzhi Dimitar /ID# 238248 Sliven Bulgaria 8800
51 Medical Center - Smolyan OOD /ID# 242361 Smolyan Bulgaria 4700
52 MHAT Dr. Bratan Shukerov /ID# 235498 Smolyan Bulgaria 4700
53 Medical center for eye healt Focus Ltd /ID# 235575 Sofia Bulgaria 1303
54 Pentagram Eye Hospital /Id# 235813 Sofia Bulgaria 1309
55 Specialized Hospital for Active Treatment in Ocular Diseases "Zrenie" /ID# 235500 Sofia Bulgaria 1408
56 Diagnostic consultative center Aleksandrovska /ID# 238105 Sofia Bulgaria 1431
57 St. Sofia Hospital /ID# 235525 Sofia Bulgaria 1618
58 Medical Center -Verea /ID# 235494 Stara Zagora Bulgaria 6000
59 Medical center Orfey /ID# 237344 Stara Zagora Bulgaria 6000
60 MHAT Trakia /ID# 238137 Stara Zagora Bulgaria 6004
61 Specialized Ophthalmological Hospital for Active Treatment - Varna /ID# 235962 Varna Bulgaria 9002
62 Ocni klinika Pardubice /ID# 235944 Pardubice Czechia 530 02
63 Fakultni nemocnice Kralovske Vinohrady /ID# 234323 Praha Czechia 100 34
64 Vseobecna fakultni nemocnice v Praze /ID# 234422 Praha Czechia 128 08
65 Rigshospitalet Glostrup /ID# 235743 Glostrup Hovedstaden Denmark 2600
66 Universitatsklinikum Freiburg /ID# 238048 Freiburg im Breisgau Baden-Wuerttemberg Germany 79106
67 Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 237069 Kiel Schleswig-Holstein Germany 24105
68 Klinikum Dresden Friedrichstadt /ID# 235308 Dresden Germany 01067
69 Universitaetsmedizin Goettingen /ID# 237377 Goettingen Germany 37075
70 Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 237247 Hamburg Germany 20246
71 Asklepios Kinik Nord - Heidberg Augenklinik /ID# 235955 Hamburg Germany 22417
72 St. Franziskus-Hospital /ID# 237714 Muenster Germany 48145
73 Dietrich-Bonhoeffer-Klinikum /ID# 235262 Neubrandenburg Germany 17036
74 Universitaetsmedizin Rostock /ID# 237263 Rostock Germany 18057
75 Augenzentrum Dr Hamacher /ID# 235537 Starnberg Germany 82319
76 Bugat Pal Korhaz /ID# 238144 Gyöngyös Heves Hungary 3200
77 Markusovszky Egyetemi Oktatokorhaz /ID# 237383 Szombathely Vas Hungary 9700
78 Budapest Retina Intezet /ID# 235950 Budapest Hungary 1133
79 Jahn Ferenc Del-pesti Korhaz es Rendelointezet /ID# 237111 Budapest Hungary 1204
80 Royal Victoria Eye and Ear Hospital /ID# 235546 Dublin Ireland 2
81 Institute of Eye Surgery /ID# 235547 Waterford Ireland X91 DH9W
82 University of Catanzaro /ID# 238066 Catanzaro Calabria Italy 88100
83 Eye Clinic University of Catania /ID# 235573 Catania Italy 95123
84 Ospedale Ss. Annunziata /ID# 236587 Chieti Italy 66100
85 Fondazione IRCCS Policlinico /ID# 236909 Pavia Italy 27100
86 University of Perugia /ID# 235811 Perugia Italy 06156
87 Fondazione Bietti - Ospedale Britannico /ID# 235495 Rome Italy 00184
88 Ospedale Fiorini di Terracina /ID# 237451 Terracina Italy 04019
89 Southern Eye Specialists /ID# 236080 Christchurch Canterbury New Zealand 8013
90 Capital Eye Specialists /ID# 236112 Wellington New Zealand 6011
91 Wojskowy Instytut Medyczny /ID# 237031 Warsaw Mazowieckie Poland 04-349
92 Optinum Profesorskie Centrum Okulistyki /ID# 237076 Gdansk Pomorskie Poland 80-809
93 Gabinet Okulistyczny Edward Wylegala /ID# 235946 Katowice Poland 40-594
94 Medical Center Julianow /ID# 235961 Lodz Poland 91-485
95 Centrum Diagnostyki i Mikrochirurgii Oka - LENS dr n. med. Slawomir Zalewski /ID# 235928 Olsztyn Poland 10-424
96 S. Fyodorov Eye Microsurgery Federal State Institution /ID# 235984 Novosibirsk Russian Federation 630071
97 Clinical ophthalmology hospital n.a. V.P. Vihodtsev. /ID# 236042 Omsk Russian Federation 644024
98 Pretoria Eye Institute - Private Practice /ID# 235658 Pretoria Gauteng South Africa 0083
99 Somerset Eye Specialist Medical & Surgical Centre /ID# 235540 Somerset West Western Cape South Africa 7130
100 Norrlands University hospital /ID# 237553 Umea Vasterbottens Lan Sweden 581 85
101 The Princess Alexandra NHS Trust /ID# 234433 Harlow Essex United Kingdom CM20 1QX
102 Oxford University Hospitals NHS Foundation Trust /ID# 237282 Oxford Oxfordshire United Kingdom OX3 9DU
103 Epsom /ID# 235931 Epsom Surrey United Kingdom KT18 7EG
104 Birmingham & Midland Eye Center /ID# 235067 Birmingham United Kingdom B18 7QH
105 Cambridge University Hospitals NHS Foundation Trust /ID# 238255 Cambridge United Kingdom CB2 0QQ
106 Mid Essex Hospitals NHS Trust /ID# 237776 Chelmsford United Kingdom CM1 7ET
107 East Suffolk and North Essex NHS Foundation Trust /ID# 234657 Colchester United Kingdom CO4 5JL
108 Mid-Cheshire Hospitals NHS Trust /ID# 235418 Crewe United Kingdom CW1 4QJ
109 Liverpool University Hospitals NHS Foundation Trust /ID# 237095 Liverpool United Kingdom L7 8XP
110 Liverpool University Hospitals NHS Foundation Trust /ID# 237321 Liverpool United Kingdom L7 8XP
111 Central Middlesex Hospital /ID# 236216 London United Kingdom NW10 7NS
112 King's College Hospital NHS Foundation Trust /ID# 237275 London United Kingdom SE5 9RS
113 York and Scarborough Teaching Hospitals NHS Foundation Trust /ID# 237683 York United Kingdom YO31 8HE

Sponsors and Collaborators

  • AbbVie

Investigators

  • Study Director: ABBVIE INC., AbbVie

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
AbbVie
ClinicalTrials.gov Identifier:
NCT03850782
Other Study ID Numbers:
  • 1698-301-007
  • 2018-002574-52
First Posted:
Feb 22, 2019
Last Update Posted:
Aug 18, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by AbbVie
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2022